Understanding the Genetic Subtypes of ARHR

Autosomal Recessive Hypophosphatemic Rickets (ARHR) is a group of extremely rare genetic disorders that disrupt how the body manages phosphate, a mineral essential for building strong bones ^[1]. In these conditions, the body has excess activity of a hormone called Fibroblast Growth Factor 23 (FGF23) ^[2].

Normally, FGF23 acts like a valve in the kidneys, helping the body get rid of extra phosphate. However, in ARHR, the kidneys flush out too much phosphate into the urine—a process called renal phosphate wasting—leaving the blood and bones starved of the mineral ^[3]. This leads to rickets (softening and weakening of bones in children) or osteomalacia (the adult version), which can cause bone pain, bowing of the legs, and short stature ^[4][5].

Because these conditions are autosomal recessive, a person typically only develops the disorder if they inherit two copies of a mutated gene—one from each parent. There are three main subtypes of ARHR, each caused by a mutation in a different gene. The age when symptoms begin varies by gene and phenotype; some forms appear in infancy, while others may not be recognized until much later.

ARHR1: The DMP1 Mutation

ARHR1 is caused by mutations in the DMP1 gene (Dentin Matrix Acidic Phosphoprotein 1) ^[2]. This gene is normally active in osteocytes (mature bone cells), where it helps regulate the production of FGF23.

• The Mechanism: Under normal conditions, DMP1 helps regulate FGF23 production. When the DMP1 gene is mutated, the bone cells churn out excessive amounts of FGF23 ^[1].
• The Rarity: This is an extremely rare condition, with only a few dozen cases reported in medical literature worldwide ^[6].
• Key Features: Beyond the typical bone softening, some patients with ARHR1 experience dental abscesses, hearing loss, and significant bone pain ^[4]. Interestingly, while the long bones in the arms and legs may be thin or bowed, the bones in the center of the body (like the spine) can sometimes appear unusually dense on scans ^[4].

ARHR2: The ENPP1 Dual Challenge

ARHR2 is caused by mutations in the ENPP1 gene and presents a “dual pathology”—meaning it affects the body in two distinct ways ^[3]. This gene is responsible for creating a substance called pyrophosphate (PPi).

1. Reduced Pyrophosphate (Ectopic Calcification): Pyrophosphate is a natural “anti-freeze” for minerals; it prevents calcium from hardening in places it doesn’t belong. When ENPP1 function is reduced, levels of PPi drop, allowing calcium to deposit in soft tissues like arteries, heart valves, and joints—a process called ectopic calcification ^[7][8].
2. Excess FGF23 (Phosphate Wasting): At the same time, the altered ENPP1 pathway triggers the body to have excess FGF23 activity, leading to the same phosphate wasting and rickets seen in other forms of the disease ^[3][9].

ARHR2 is part of a spectrum of disease. Some infants are born with a severe version called Generalized Arterial Calcification of Infancy (GACI), while others develop the rickets symptoms (ARHR2) later in childhood or adulthood ^[5]. Research in select cohorts suggests that roughly 70% of those with the ARHR2 phenotype also have some evidence of internal calcification ^[10]. Genetic estimates predict ENPP1 mutations may occur in roughly 1 in 64,000 to 1 in 200,000 pregnancies, though this is a predicted genetic frequency, not a count of clinically diagnosed cases ^[11][12].

ARHR3: The FAM20C Mutation (Raine Syndrome)

The third subtype, ARHR3, involves mutations in the FAM20C gene. This gene is responsible for phosphorylating certain proteins (including FGF23) so the body can process them correctly ^[1].

• The Mechanism: When FAM20C is mutated, FGF23 phosphorylation and cleavage are disrupted. This allows active FGF23 to persist, once again leading to low blood phosphate ^[13].
• The Spectrum: Mutations in this gene can cause Raine Syndrome. While some forms are very severe and affect bone development before birth, other “non-lethal” forms primarily cause hypophosphatemic rickets, dental issues like amelogenesis imperfecta (weak tooth enamel), and distinctive facial features ^[14][15].

Summary of ARHR Subtypes

Understanding which gene is responsible is a vital step in preparing for long-term care, as it helps your medical team monitor for specific complications—like the vascular health concerns in ENPP1 or the specific dental and hearing needs reported across different subtypes ^[12][16].